Tech Innovators Secure Over $300 Million in Funding for AI and Biotech Ventures

Former Google AI expert, Andrew Ng, has raised $100 million in funding for his biotech start-up, Inception, which aims to use artificial intelligence to accelerate drug discovery and development. The company plans to leverage AI algorithms to analyze vast amounts of biomedical data and identify potential drug candidates, with the goal of bringing new treatments to market faster and more efficiently. Ng's expertise in AI and his successful track record in the tech industry have attracted significant investment, positioning Inception as a promising player in the biotech space.